ABREVA (GlaxoSmithKline Consumer Healthcare Holdings (US) LLC)
Welcome to the PulseAid listing for the ABREVA drug offered from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| NON-PROPRIETARY NAME: | docosanol |
| SUBSTANCE NAME: | DOCOSANOL |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-03-19 |
| END MARKETING DATE: | 0000-00-00 |
ABREVA HUMAN OTC DRUG Details:
| Item Description | ABREVA from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| LABELER NAME: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/g) |
| START MARKETING DATE: | 2010-03-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0135-0200_9dc75a87-9221-4109-a50e-80edb8938022 |
| PRODUCT NDC: | 0135-0200 |
| APPLICATION NUMBER: | NDA020941 |
Other DOCOSANOL Pharmaceutical Manufacturers / Labelers:
